🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Status
Unknown
Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
Start Date
2015-10
Trial ID
NCT02580747
Treatments Being Tested
This study is a single-center, open Phase I study, to observe the effective...
Status
Unknown
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2022-01-01
Trial ID
NCT05201118
RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2013-06
Trial ID
NCT01886976
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficiency of autol...
Status
Active Not Recruiting
Location
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Start Date
2020-07-27
Trial ID
NCT04499573
Treatments Being Tested
This is an open-lable, single-arm, single-dose escalation and multiple-dose...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2020-05
Trial ID
NCT04357509
Treatments Being Tested
This phase I/IIa trial studies the side effects and best dose of gene-modif...
Status
Active Not Recruiting
Location
Roswell Park Cancer Institute
Start Date
2017-07-14
Trial ID
NCT02650986
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-04-15
Trial ID
NCT06094842
This is a single-center, non-randomized study to evaluate the safety and ef...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2019-10-23
Trial ID
NCT04295018
Treatments Being Tested
This intermediate-size IND will treat participants with incurable, advanced...
Status
Temporarily Not Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT05389514
Treatments Being Tested
This study is a single-armed, open-label, multicenter Phase 1/2 study to ev...
Status
Not Yet Recruiting
Location
Institute of Science Tokyo Hospital
Start Date
2026-05-10
Trial ID
NCT07510100
Treatments Being Tested